Breathe Well Live Well
|
Teva's injectable asthma biologic approved by FDA
The Pharmaceutical Journal The biologic treatment, which is given as a four-weekly infusion alongside other drugs, is indicated to help those patients with severe asthma who still have serious asthma attacks despite being on regular medication. It is expected to be launched in … |
View full post on asthma – Google News
International Business Times |
Glaxo's Injectable Asthma Treatment 'Nucala' Gets Approval From FDA
International Business Times The U.S. Food and Drug Administration (FDA) has given a go ahead to GlaxoSmithKline Plc's drug Nucala for treatment of severe asthma. The regulato6ry body said that the drug can be used in combination with other therapies and medications for asthma … FDA Approves New Asthma Medication Mepolizumab gets green signal from FDA to be used for maintenance treatment of … GlaxoSmithKline plc (ADR): Why Nucala's FDA Approval Is Significant |
View full post on asthma – Google News
Yahoo News |
EU regulator backs approval for GSK injectable asthma drug
Yahoo News The treatment could help boost GSK's respiratory drugs business as demand weakens for its asthma drug, Advair. A significant minority of asthma patients do not respond to regular inhalers such as Advair, Dulera and Flovent, creating what analysts … Glaxo asthma drug clears key hurdle in Europe CHMP Backs Mepolizumab for Severe Eosinophilic Asthma GlaxoSmithKline's asthma injection heads for EU approval |
View full post on asthma – Google News
Reuters |
EU regulator backs approval for GSK injectable asthma drug
Reuters GlaxoSmithKline Plc said the European health regulator had recommended an approval for its injectable drug to treat asthma patients who don't respond well to traditional inhalers. The European Commission is expected to decide on a final approval for … Glaxo asthma drug clears key hurdle in Europe GlaxoSmithKline's asthma injection heads for EU approval Europe's CHMP give thumbs up to Glaxo's Nucala for severe asthma |
View full post on asthma – Google News
Condition: Anesthesia
Interventions: Drug: lidocaine-epinephrine; Drug: Topicaine gel
Sponsor: David Grant U.S. Air Force Medical Center
Enrolling by invitation – verified February 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days